Signifor LAR 40 MG
Ended Awarded
- Contract number
- 36C24525N1014
- Awardee
-
Recordati Rare Diseases Inc. UEI LL38YHW3Y9P4
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $44,877
Award facts
- Contract value 100% obligated
- $44,876.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a $44.9K firm fixed-price delivery order to Recordati Rare Diseases Inc. for Signifor LAR 40 mg, a specialized pharmaceutical product used in the treatment of rare endocrine disorders such as Cushing's disease and acromegaly. The award was issued on September 19, 2025, with an ultimate completion date of September 23, 2025, and will be performed in Bartlett, Tennessee. This delivery order was placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with no set-aside designation.
This award represents a continuation of the VA's established relationship with Recordati Rare Diseases Inc., a foreign-owned pharmaceutical manufacturer specializing in rare disease treatments. The delivery order falls under one of two significant indefinite-delivery vehicles the company holds with the VA: a $15.6M multiple-award Federal Supply Schedule contract (April 2021–April 2026) and a $3.16M single-award Blanket Purchase Agreement (July 2021–July 2026) covering Signifor and other rare disease pharmaceuticals. These IDVs provide the VA with streamlined access to Recordati's specialized medications to support veteran healthcare needs across multiple service networks and regions.
Quick answers
Who was awarded contract 36C24525N1014?
36C24525N1014 was awarded to Recordati Rare Diseases Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on September 19, 2025.
How much is contract 36C24525N1014 worth?
The government has obligated $44,877 on 36C24525N1014.
Is contract 36C24525N1014 an order under another contract?
Yes. 36C24525N1014 is a delivery order under 36F79721D0141, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N1014 competed?
The extent of competition for 36C24525N1014 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award